Phase II trial of embolization with NBCA-lipiodol mixture (JIVROSG-0802)
Not Applicable
- Conditions
- active bleeding, pseudoaneurysm, true aneurysm, vascular malformation, arteriovenous fistula, and embolization in vascular intervention
- Registration Number
- JPRN-UMIN000012564
- Lead Sponsor
- Japan Interventional Radiology In Oncology Study Group(JIVROSG)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 65
Inclusion Criteria
Not provided
Exclusion Criteria
1. Allergic histories for iodininated contrast medium or lipiodol. 2. CNS arteriovenous malformation 3. Cerebral aneurysm 4. DIC 5. Uncontrollable shock 6. Endoleak after aortic stent placement 7. Pregnant woman, or pegnancy is suspected 8. Radiologist judged that the patients is not suitable for the present study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy: Success rate of embolization with NBCA-lipiodol mixture
- Secondary Outcome Measures
Name Time Method Safety: Frequency of adverse events